Citation Impact
Citing Papers
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Targeted cell killing by reconstituted caspases
2007 StandoutNobel
Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression
2013 StandoutNobel
The microbiota regulates type 2 immunity through RORγt + T cells
2015 StandoutScienceNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
2009 Standout
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments
2008
TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis
2013
Tolerization of Tumor-Specific T Cells Despite Efficient Initial Priming in a Primary Murine Model of Prostate Cancer
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Prostate Stroma: Physiology
1999
Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: Evidence for the role of cell death genes
1990
Inflammation and cancer
2002 StandoutNature
Endogenous inhibitors of angiogenesis
2009
The polarization of immune cells in the tumour environment by TGFβ
2010
Control of type-D GABAergic neuron differentiation by C. elegans UNC-30 homeodomain protein
1994 StandoutNatureNobel
Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
2009
Synthesis of Biomolecule‐Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells
2011 StandoutNobel
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
1993 Standout
IL3-Dependent Cells Die by Apoptosis on Removal of their Growth Factor
1991
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
The C. elegans Cell Corpse Engulfment Gene ced-7 Encodes a Protein Similar to ABC Transporters
1998 StandoutNobel
Regulatory T Cells in Cancer
2010
The generation of diversity and pattern in animal development
1992 StandoutNobel
Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation
2010
Mechanisms and Functions of Cell Death
1991 Standout
TGFβ: the molecular Jekyll and Hyde of cancer
2006
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
2018
An Alternatively Spliced C. elegans ced-4 RNA Encodes a Novel Cell Death Inhibitor
1996 StandoutNobel
Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model
2003
Persistent and transcriptionally-dependent increase in protein phosphorylation in long-term facilitation ofAplysia sensory neurons
1989 StandoutNatureNobel
Hormonal, cellular, and molecular control of prostatic development
2003
Rewiring T-cell responses to soluble factors with chimeric antigen receptors
2018
Immune surveillance of tumors
2007
TGF‐β limits IL‐33 production and promotes the resolution of colitis through regulation of macrophage function
2011
The C. elegans Protein EGL-1 Is Required for Programmed Cell Death and Interacts with the Bcl-2–like Protein CED-9
1998 StandoutNobel
The emerging roles of forkhead box (Fox) proteins in cancer
2007
Molecular genetics of prostate cancer
2000
How regulatory T cells work
2008 Standout
Gr‐1+CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression
2012
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
2009 Standout
Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor
1997 StandoutNatureNobel
Intraclonal competition limits the fate determination of regulatory T cells in the thymus
2009
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Transforming growth factor beta (TGF-β) and inflammation in cancer
2009
Cholinergic innervation and function in the prostate gland
2002
Mechanisms of Immune Evasion by Tumors
2006
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
2003
Regulatory T cells in tumor immunity
2010 StandoutNobel
The Human Plasma Proteome
2002 Standout
The TRA-1A Sex Determination Protein of C. elegans Regulates Sexually Dimorphic Cell Deaths by Repressing the egl-1 Cell Death Activator Gene
1999 StandoutNobel
C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
1994 StandoutNobel
Activation of C. elegans cell death protein CED-9 by an ammo-acid substitution in a domain conserved in Bcl-2
1994 StandoutNatureNobel
Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein
1995 StandoutNatureNobel
Tumors and inflammatory infiltrates: Friends or foes?
2002
C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180
1998 StandoutNatureNobel
Activin receptor‐like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
2014
Activin receptor‐like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
2013
Endogenous Inhibitors of Angiogenesis
2005
An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.
1993 StandoutNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells
2012
The Steroid and Thyroid Hormone Receptor Superfamily
1988 StandoutScience
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
von Hippel-Lindau Disease
2006 StandoutNobel
MOD-1 is a serotonin-gated chloride channel that modulates locomotory behaviour in C. elegans
2000 StandoutNatureNobel
Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas Cancer
2008
Treg functional stability and its responsiveness to the microenvironment
2014
Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero
1998 StandoutNobel
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities.
1996 StandoutNobel
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types
2002 StandoutNobel
Steroid Hormone Receptors in Human Breast Cancer
1983
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.
1993
Genetically targeted cell disruption in Caenorhabditis elegans
1997 StandoutNobel
Two-dimensional gel electrophoresis of proteins
1987
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Induced CD4+Foxp3+Regulatory T Cells in Immune Tolerance
2012
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma
2017
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
Translocation of C. elegans CED-4 to Nuclear Membranes During Programmed Cell Death
2000 StandoutScienceNobel
Immune Therapy for Cancer
2008
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death
1992 StandoutNobel
Works of Chung Lee being referenced
Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor β–Insensitive CD8+ T Cells
2009
Partial inhibition of castration induced ventral prostate regression with actinomycin D and cycloheximide.
1978
Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β
2007
Cutting Edge: TGF-β-Induced Expression of Foxp3 in T cells Is Mediated through Inactivation of ERK
2008
Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (renca) cells
1999
Epidermal growth factor-related peptides in human prostatic fluid: Sources of variability in assay results
1997
Pigment epithelium–derived factor regulates the vasculature and mass of the prostate and pancreas
2003
Determination of prostatic secretion in rats: Effect of neurotransmitters and testosterone
1991
Comparison of mononuclear cell proteins and plasma proteins before and during parturition by two dimensional electrophoresis
1991
Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein
2000
TGF-?-based immunotherapy for cancer: Breaching the tumor firewall
2000
Growth of the Rat Prostate Gland is Facilitated by the Autonomic Nervous System1
1994
Prostatic Ductal System in Rats: Regional Variation in Morphological and Functional Activities1
1990
Restoration of expression of transforming growth factor-β Type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2′-deoxycytidine
2004
Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate
1991
Differential Cytokeratin Expression in Normal, Hyperplastic and Malignant Epithelial Cells From Human Prostate
1990
Prostate innervation
1998
Adoptive Transfer of Tumor-Reactive Transforming Growth Factor-β–Insensitive CD8+ T Cells: Eradication of Autologous Mouse Prostate Cancer
2005
Effect of Dominant Negative Transforming Growth Factor-β Receptor Type II on Cytotoxic Activity of RAW 264.7, a Murine Macrophage Cell Line
2007
Systematic characterization of human prostatic fluid proteins with two-dimensional electrophoresis.
1984
Blockade of transforming growth factor-β signaling in tumor-reactive CD8+ T cells activates the antitumor immune response cycle
2006
Reconstitution of Lethally Irradiated Adult Mice with Dominant Negative TGF-β Type II Receptor-Transduced Bone Marrow Leads to Myeloid Expansion and Inflammatory Disease
2002
Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.
1998
Effect of ovariectomy on serially transplanted rat mammary tumors induced by 7,12-dimethylbenz[α]anthracene
1981
Elevated Transferrin Receptor Content in Human Prostate Cancer Cell Lines Assessed in Vitro and in Vivo
1990
Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice.
2002